Clinical Trial: Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279298) titled 'Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV' on Dec. 01.

Brief Summary: This study aims to evaluate the real-world effectiveness of two preventive immunization strategies against Respiratory Syncytial Virus (RSV)-associated severe acute respiratory infection in infants less than six months of age in Bogota, Colombia. The strategies include maternal vaccination with RSVpreF administered between 28 and 36 weeks of gestation and neonatal immunization with nirsevimab for infants born to mothers who did not receive RSVpreF during pregnancy. Using a test-negative case-control design embedded in the c...